{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:16:13Z","timestamp":1790244973424,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Funds for Statutory Activity of Maria Curie-Sk\u0142odowska University, Lublin, Poland"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.pbb.2012.08.012","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T22:47:05Z","timestamp":1345848425000},"page":"273-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice"],"prefix":"10.1016","volume":"103","author":[{"given":"Katarzyna","family":"Soca\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Nieoczym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2012.08.012_bb0005","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/BF00980590","article-title":"Physiological effects of alarm chemosignal emitted during the forced swim","volume":"19","author":"Abel","year":"1993","journal-title":"J Chem Ecol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2008.03.038","article-title":"Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice","volume":"587","author":"Akula","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00702-007-0806-5","article-title":"Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies","volume":"115","author":"Brink","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2012.08.012_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/3228","article-title":"Discovery of the nitric oxide signaling pathway and targets for drug development","volume":"14","author":"Bryan","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.pbb.2012.08.012_bb0295","series-title":"Antidepressants: past, present and future","first-page":"87","article-title":"Therapeutic drug monitoring of antidepressants","author":"Burke","year":"2004"},{"key":"10.1016\/j.pbb.2012.08.012_bb0300","first-page":"5.8.1","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","author":"Castagne","year":"2007","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1999.tb09320.x","article-title":"Cholinergic, M1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine","volume":"877","author":"Chau","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pbb.2012.08.012_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2012.08.012_bb0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.pnpbp.2007.02.008","article-title":"Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice","volume":"31","author":"Dhir","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.08.012_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2007.04.028","article-title":"Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor","volume":"568","author":"Dhir","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1472-8206.2008.00605.x","article-title":"Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor","volume":"22","author":"Dhir","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0165-0173(86)90016-0","article-title":"Cholinergic mechanisms in depression","volume":"396","author":"Dilsaver","year":"1986","journal-title":"Brain Res"},{"issue":"Suppl. 2","key":"10.1016\/j.pbb.2012.08.012_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/sj.ijir.3901243","article-title":"Specific aspects of erectile dysfunction in psychiatry","volume":"16","author":"Farre","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pbb.2012.08.012_bb0075","first-page":"106","article-title":"15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL","volume":"7","author":"Fava","year":"2005","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2012.08.012_bb0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4088\/JCP.v67n0210","article-title":"Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial","volume":"67","author":"Fava","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2012.08.012_bb0080","first-page":"653","article-title":"Paroxetine is a novel nitric oxide synthase inhibitor","volume":"32","author":"Finkel","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pbb.2012.08.012_bb0085","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.biopsych.2005.07.011","article-title":"A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters","volume":"59","author":"Gould","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.08.012_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00191-0","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test","volume":"372","author":"Harkin","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0090","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0100","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.bcp.2010.07.037","article-title":"Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues","volume":"80","author":"Harvey","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-4328(02)00084-0","article-title":"Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats","volume":"134","author":"Heiberg","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.08.012_bb0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.physbeh.2004.09.005","article-title":"Aggressive behavior increases after termination of chronic sildenafil treatment in mice","volume":"83","author":"Hotchkiss","year":"2005","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2012.08.012_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2125.2001.00318.x","article-title":"Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil","volume":"51","author":"Hyland","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pbb.2003.12.024","article-title":"Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation","volume":"77","author":"Inan","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2012.08.012_bb0125","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0006-8993(01)02673-7","article-title":"Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway","volume":"909","author":"Jain","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2012.08.012_bb0305","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic-adrenergic hypothesis of mania and depression","volume":"2","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2012.08.012_bb0310","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00006842-197405000-00008","article-title":"Acetylcholine and depression","volume":"36","author":"Janowsky","year":"1974","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pbb.2012.08.012_bb0140","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0006-8993(99)01599-1","article-title":"Nitric oxide modulates the release of serotonin in the rat hypothalamus","volume":"835","author":"Kaehler","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2012.08.012_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbr.2010.11.027","article-title":"The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis","volume":"218","author":"Krass","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.08.012_bb0150","first-page":"353","article-title":"Effect of sildenafil on anxiety in the plus-maze test in mice","volume":"56","author":"Kurt","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0155","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0269881106059692","article-title":"Inhibition of N-methyl-D-aspartate receptor function appears to be one of the common actions for antidepressants","volume":"20","author":"Li","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","article-title":"Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice","volume":"155","author":"Lucki","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2012.08.012_bb0165","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2012.08.012_bb0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2012.08.012_bb0175","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1345\/aph.1A402","article-title":"Neurologic, psychological, and aggressive disturbances with sildenafil","volume":"36","author":"Milman","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pbb.2012.08.012_bb0195","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1734-1140(09)70151-3","article-title":"Lack of effect of sildenafil on cocaine-induced convulsions in mice","volume":"61","author":"Nieoczym","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pbb.2012.08.012_bb0180","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1528-1167.2009.02485.x","article-title":"Effect of sildenafil on the anticonvulsant action of classical and second-generation antiepileptic drugs in maximal electroshock-induced seizures in mice","volume":"51","author":"Nieoczym","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2012.08.012_bb0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1734-1140(10)70278-4","article-title":"Effects of sildenafil on pentylenetetrazol-induced convulsions in mice and amygdala-kindled seizures in rats","volume":"62","author":"Nieoczym","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pbb.2012.08.012_bb0315","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00702-012-0767-1","article-title":"Influence of sildenafil on the anticonvulsant action of selected antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice","volume":"119","author":"Nieoczym","year":"2012","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2012.08.012_bb0200","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00131746-200103000-00003","article-title":"Managing treatment-emergent sexual dysfunction associated with serotonergic antidepressants: before and after sildenafil","volume":"7","author":"Nurnberg","year":"2001","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.pbb.2012.08.012_bb0205","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1176\/appi.ajp.158.11.1926","article-title":"Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors","volume":"158","author":"Nurnberg","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2012.08.012_bb0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(02)01691-6","article-title":"Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression","volume":"60","author":"Nurnberg","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.pbb.2012.08.012_bb0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.289.1.56","article-title":"Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial","volume":"289","author":"Nurnberg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pbb.2012.08.012_bb0225","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867043455594","article-title":"Trends in the development of new antidepressants. Is there a light at the end of the tunnel?","volume":"11","author":"Pacher","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pbb.2012.08.012_bb0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051156","article-title":"Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test","volume":"147","author":"Page","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2012.08.012_bb0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2012.08.012_bb0235","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pbb.2012.08.012_bb0240","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\u201cBehavioural despair\u201d in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0245","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bjp.0706680","article-title":"The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway","volume":"147","author":"Riazi","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(94)00711-F","article-title":"Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats","volume":"274","author":"Rundfeldt","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0255","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1176\/appi.ajp.158.10.1623","article-title":"Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate","volume":"158","author":"Seidman","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2012.08.012_bb0260","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001035","article-title":"Nicotinic acetylcholine receptors as targets for antidepressants","volume":"7","author":"Shytle","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2012.08.012_bb0265","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1192\/bjp.180.5.396","article-title":"Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis","volume":"180","author":"Smith","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2012.08.012_bb0270","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00702-011-0756-9","article-title":"Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice","volume":"119","author":"Soca\u0142a","year":"2012","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2012.08.012_bb0275","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0149-2918(08)80047-1","article-title":"Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update","volume":"30","author":"Spina","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.pbb.2012.08.012_bb0280","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.yic.0000117902.43995.b0","article-title":"Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression","volume":"19","author":"Tignol","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2012.08.012_bb0285","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(02)03738-1","article-title":"Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity","volume":"959","author":"Wegener","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2012.08.012_bb0290","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0731-7085(03)00314-5","article-title":"HPLC determination and pharmacokinetics of sustained-release bupropion tablets in dogs","volume":"33","author":"Zhang","year":"2003","journal-title":"J Pharm Biomed Anal"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571200233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571200233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:31:36Z","timestamp":1758774696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009130571200233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S009130571200233X"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2012.08.012","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2012.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}